Specialists of the Center. The Gamaleas have embarked on preclinical research on a platform for vaccines that will further protect against several different viruses or several variants of the same virus. This was announced by the director of the center, Alexander Gintsburg, reports TASS.
According to him, the vaccine is currently being tested on monkeys. The meaning of this development is that it will immediately protect against different strains of the same virus and even against different viruses that circulate in the human population at the same time. The vaccine may combine different antigens from the coronavirus and influenza viruses.
Earlier, the Mash edition, referring to the doctor of biological sciences Alexei Granovsky, informed that the Center. Gamalei began testing an additive on monkeys that could enhance the effect of Sputnik V. Gunzburg called this information false and explained that a new platform is being tested. “Sputnik V”, according to his statement, is quite effective against various strains of COVID-19 and without additives.
Gunzburg assured that the testing of the new additive had nothing to do with Sputnik V.
Earlier it was reported that the registration of a new drug from COVID-19, Mir-19, had begun in Russia. The drug developers said they expect to register it by the end of 2021.
The United States responded to the Russian statement about the incident with the destroyer
Fire breaks out in rebellious Russian colony
USA to close the entrance for those vaccinated by “Sputnik V”
